Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction (Q34352062)

1 August 2017

1 reference

title

Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction (English)

1 reference

1 August 2017

1 reference

1

Deeg HJ

1 reference

1 August 2017

publication date

1 July 2001

1 reference

International Journal of Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

74

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

26-32

1 reference

Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease

1 August 2017

cites work

1 reference

12 December 2020

Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease

1 reference

12 December 2020

Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production

1 reference

12 December 2020

Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease

1 reference

12 December 2020

IFN-gamma-mediated prevention of graft-versus-host disease: pharmacodynamic studies and influence on proliferative capacity of chimeric spleen cells

1 reference

12 December 2020

Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease

1 reference

12 December 2020

Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease

1 reference

12 December 2020

Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.

1 reference

12 December 2020

Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells

1 reference

12 December 2020

Graft-versus-leukemia effect and graft-versus-host disease can be differentiated by cytotoxic mechanisms in a murine model of allogeneic bone marrow transplantation

1 reference

12 December 2020

Graft-vs.-lymphoma effect in an allogeneic hematopoietic stem cell transplantation model

1 reference

12 December 2020

Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin

1 reference

12 December 2020

Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice

1 reference

12 December 2020

Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice

1 reference

12 December 2020

Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants

1 reference

12 December 2020

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

1 reference

12 December 2020

Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression

1 reference

12 December 2020

Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway

1 reference

12 December 2020

Aberrant CD3- and CD28-mediated signaling events in cord blood T cells are associated with dysfunctional regulation of Fas ligand-mediated cytotoxicity

1 reference

12 December 2020

Fas-deficient lpr mice are more susceptible to graft-versus-host disease

1 reference

12 December 2020

1 reference

12 December 2020

Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL

1 reference

12 December 2020

Prevention of graft-versus-host disease by induction of immune tolerance with ultraviolet B-irradiated leukocytes in H-2 disparate bone marrow donor.

1 reference

12 December 2020

Endogenous interleukin 1 receptor antagonist during human bone marrow transplantation: increased levels during graft-versus-host disease, during infectious complications, and after immunoglobulin therapy

1 reference

12 December 2020

Interleukin-11 reduces T-cell-dependent experimental liver injury in mice

1 reference

12 December 2020

Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants

1 reference

12 December 2020

Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease

1 reference

12 December 2020

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

1 reference

12 December 2020

Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation

1 reference

12 December 2020

Murine IL-10 fails to reduce GVHD despite inhibition of alloreactivity in vitro

1 reference

12 December 2020

G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function

1 reference

12 December 2020

Decreased graft-versus-host disease after haplotype mismatched bone marrow allografts in miniature swine following interleukin-2 treatment

1 reference

12 December 2020

Upregulation of interleukin-10 and inhibition of alloantigen responses by transferrin and transferrin-derived glycans

1 reference

12 December 2020

Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines

1 reference

12 December 2020

The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.

1 reference

12 December 2020

Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

1 reference

12 December 2020

Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients

1 reference

12 December 2020

Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation

1 reference

12 December 2020

Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice

1 reference

12 December 2020

Pathophysiologic mechanisms of acute graft-vs.-host disease

1 reference

12 December 2020

Effects of UVB radiation on cytokine generation, cell adhesion molecules, and cell activation markers in T-lymphocytes and peripheral blood HPCs.

1 reference

12 December 2020

Analysis of Fas system in pulmonary injury of graft-versus-host disease after rat intestinal transplantation

1 reference

12 December 2020

Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT)

1 reference

12 December 2020

Treatment of acute graft-versus-host disease with monoclonal antibody to IL-2 receptor

1 reference

12 December 2020

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates

1 reference

12 December 2020

Cutting edge: sustained expansion of CD8+ T cells requires CD154 expression by Th cells in acute graft versus host disease

1 reference

12 December 2020

Differential roles of IL-1 and TNF-alpha on graft-versus-host disease and graft versus leukemia

1 reference

12 December 2020

Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease

1 reference

12 December 2020

Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation.

1 reference

12 December 2020

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease

1 reference

12 December 2020

Graft-versus-host-disease-associated lymphoid hypoplasia and B cell dysfunction is dependent upon donor T cell-mediated Fas-ligand function, but not perforin function

1 reference

12 December 2020

Prolonged secretion of IL-15 in patients with severe forms of acute graft-versus-host disease after allogeneic bone marrow transplantation in children

1 reference

12 December 2020

Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.

1 reference

12 December 2020

Role of recombinant interleukin-2 (rIL-2) and large granular lymphocytes (LGLs) in acute rat graft-versus-host disease (GVHD).

1 reference

12 December 2020

Recombinant human interleukin-1 receptor antagonist in the treatment of steroid-resistant graft-versus-host disease.

1 reference

12 December 2020

Serum cytokine levels after HLA-identical bone marrow transplantation

1 reference

12 December 2020

Blockade of CD134 (OX40)-CD134L interaction ameliorates lethal acute graft-versus-host disease in a murine model of allogeneic bone marrow transplantation

1 reference

12 December 2020

Immunotherapeutic aspects of allogeneic peripheral progenitor cells

1 reference

12 December 2020

Analysis of cytokine production and V beta T-cell receptor subsets in irradiated recipients receiving portal or peripheral venous reconstitution with allogeneic bone marrow cells, with or without additional anti-cytokine monoclonal antibodies

1 reference

12 December 2020

The role of cytokines in graft-versus-host reactions and disease

1 reference

12 December 2020

Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.

1 reference

12 December 2020

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

12 December 2020

Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.

1 reference

12 December 2020

PRETRANSPLANT CHEMOTHERAPY REDUCES INFLAMMATORY CYTOKINE PRODUCTION AND ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION

1 reference

12 December 2020

Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host disease mortality after major H2 incompatible transplantation

1 reference

12 December 2020

Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies

1 reference

12 December 2020

Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets

1 reference

12 December 2020

Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses.

1 reference

12 December 2020

Separate ontogeny of two macrophage-like accessory cell populations in the human fetus

1 reference

12 December 2020

A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02982546

1 reference

Dimensions Publication ID

1 August 2017

1009323114

0 references

1 reference